Supplementary Table 1: Preclinical studies conducted on nanozyme antioxidants: shortcomings and challenges based on US FDA regulations.docx

dataset

posted on 2021-05-11, 13:14 authored by Milad Ghorbani, Zhila Izadi, Samira Jafari, Eudald Casals, Foroogh Rezaei, Alireza Aliabadi, Alycia Moore, Ali Ansari, Víctor Puntes, Mehdi Jaymand, Hossein Derakhshankhah

Table S1. An overview on the results of the papers which have conducted in vivo analysis for evaluation of nanozyme antioxidants since 2009.

Funding

This study was supported by Kermanshah University of Medical Sciences. E.C. acknowledges support from National Natural Science Foundation of China (project 31950410536).

History

Usage metrics

Keywords

Nanozyme antioxidants oxidative stress Preclinical studies FDA regulations antioxidants market Metabolic Medicine Enzymes

Licence

CC BY-NC-ND 4.0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

Supplementary Table 1: Preclinical studies conducted on nanozyme antioxidants: shortcomings and challenges based on US FDA regulations.docx

Funding

This study was supported by Kermanshah University of Medical Sciences. E.C. acknowledges support from National Natural Science Foundation of China (project 31950410536).

This study was supported by Kermanshah University of Medical Sciences. E.C. acknowledges support from National Natural Science Foundation of China (project 31950410536).

History

Usage metrics

Categories

Keywords

Licence

Exports